<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADeal_value</id>
	<title>Definition:Deal value - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ADeal_value"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Deal_value&amp;action=history"/>
	<updated>2026-06-14T16:24:35Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Deal_value&amp;diff=18078&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Deal_value&amp;diff=18078&amp;oldid=prev"/>
		<updated>2026-03-15T17:04:50Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📋 &amp;#039;&amp;#039;&amp;#039;Deal value&amp;#039;&amp;#039;&amp;#039; is the total consideration — whether expressed as cash, stock, assumed liabilities, or a combination — attributed to a [[Definition:Merger and acquisition (M&amp;amp;A) | merger, acquisition]], or divestiture transaction in the insurance sector. It serves as the headline metric by which the market, analysts, and regulators gauge the scale and significance of a transaction, whether the target is a [[Definition:Primary insurer | primary insurer]], a [[Definition:Reinsurer | reinsurer]], a [[Definition:Managing general agent (MGA) | distribution platform]], or an [[Definition:Insurtech | insurtech]] startup. Because insurance businesses carry large balance sheets relative to their earnings, deal value in this sector often reflects both the earning power of the franchise and the value — or cost — of the [[Definition:Insurance reserve | reserves]] and [[Definition:Regulatory capital | capital]] being transferred.&lt;br /&gt;
&lt;br /&gt;
💰 Arriving at deal value requires navigating valuation complexities that are distinctive to insurance. Buyers must form a view on the adequacy of the target&amp;#039;s [[Definition:Loss reserve | loss reserves]] — an area where adverse development can materially erode post-closing economics — as well as the embedded value of in-force [[Definition:Life insurance | life]] books, the quality of [[Definition:Underwriting | underwriting]] portfolios, and the durability of distribution relationships. Multiples of [[Definition:Book value | book value]], [[Definition:Price-to-earnings ratio | price-to-earnings]] ratios, and embedded-value metrics each play a role depending on the type of business. In [[Definition:Private equity | private equity]]-led insurance transactions, deal value frequently incorporates expectations around [[Definition:Cost synergy | cost synergies]], reserve releases, and investment-portfolio optimization. [[Definition:Earnout | Earnout]] structures may tie a portion of deal value to future performance, particularly in [[Definition:Managing general agent (MGA) | MGA]] and [[Definition:Insurtech | insurtech]] acquisitions where growth trajectories are uncertain.&lt;br /&gt;
&lt;br /&gt;
📊 Tracking deal value across the industry provides a barometer of market confidence, capital flows, and strategic direction. Periods of elevated deal values — such as the waves of consolidation in European insurance during the early 2000s, or the surge of [[Definition:Private equity | private equity]] investment in [[Definition:Life insurance | life]] and [[Definition:Annuity | annuity]] platforms over the past decade — signal structural shifts in how capital is being deployed and which business models investors favor. Regulators scrutinize deal value in the context of [[Definition:Change of control | change-of-control]] approvals, assessing whether the price paid implies aggressive assumptions that could compromise the acquirer&amp;#039;s [[Definition:Solvency | solvency]] or the target&amp;#039;s policyholder protections. For boards, shareholders, and advisors on both sides of a transaction, the negotiation and justification of deal value is the fulcrum around which every other decision turns.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Merger and acquisition (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Embedded value]]&lt;br /&gt;
* [[Definition:Book value]]&lt;br /&gt;
* [[Definition:Cost synergy]]&lt;br /&gt;
* [[Definition:Earnout]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>